Prevention Of WEight Regain in diabetes type 2 (POWER).
Completed
- Conditions
- Diabetes type 2Obesity/overweightDiabetes type 2Obesitas/overgewicht
- Registration Number
- NL-OMON21737
- Lead Sponsor
- Erasmus Medical Centre Rotterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 250
Inclusion Criteria
1. Diagnosed diabetes mellitus type 2;
2. Age 18-70 years;
Exclusion Criteria
1. Pregnancy or lactation during the study;
2. Inadequate expression of the Dutch language (spoken and written);
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint with respect to the efficacy of CPI, is the between-group difference in weight change (kg) measured as weight after 2 years follow-up minus weight at week 12 (directly after intervention).
- Secondary Outcome Measures
Name Time Method 1. Anthropometric measurements: BMI, waist-hip-ratio, bellycircumference, body composition (%fat and lean body mass);<br /><br>2. Cardiovascular riskprofile: HbA1c, HOMA241, bloodpressure, lipids profile;<br /><br>3. Glycaemic control: insulin, glucose;<br /><br>4. Psychological measurements: EuroQol, HADS, VOEG-13, CIS, RSE;<br /><br>5. Lifestyle: SQUASH, EDE-Q;<br /><br>6. Cost effectiveness: SRS, TIC-P.